Elective oocyte cryopreservation: who should pay?

Area of Science:

• Reproductive Medicine
• Bioethics
• Public Health Policy

Background:

• Oocyte cryopreservation (social freezing) is increasingly offered to healthy women to preserve reproductive options.
• Social freezing is not currently afforded the same public funding as standard in-vitro fertilization (IVF) treatments.
• Disparities in funding raise ethical questions regarding reproductive autonomy and justice.

Purpose of the Study:

• To advocate for equitable public funding for social freezing procedures.
• To argue for the inclusion of social freezing within existing IVF funding frameworks.
• To explore different models for covering the costs associated with oocyte cryopreservation.

Main Methods:

• Ethical argument based on principles of justice and reproductive rights.
• Analysis of current public funding policies for fertility treatments.
• Discussion of potential financial coverage models for social freezing.

Main Results:

• Current funding models create inequality between women undergoing social freezing and those undergoing standard IVF.
• Consistent application of justice principles necessitates coverage for social freezing.
• Various coverage modalities, including full coverage or reimbursement, are feasible.

Conclusions:

• Public funding should be extended to cover fertilization and transfer cycles for women who have undergone social freezing.
• Full coverage, including ovarian stimulation, oocyte retrieval, and storage, is ethically justified.
• Policy changes are needed to ensure equitable access to reproductive technologies and support reproductive autonomy.